(Q39792915)

14 September 2017

Choline in tardive dyskinesia and Huntington's disease (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

7 May 2022

0 references

1 reference

K. L. Davis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A136581

7 May 2022

L. E. Hollister

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A136581

7 May 2022

J. D. Barchas

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A136581

7 May 2022

P. A. Berger

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A136581

7 May 2022

language of work or name

English

0 references

publication date

1 November 1976

1 reference

14 September 2017

15 November 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=136581

full work available at URL

7 May 2022

https://api.elsevier.com/content/article/PII:0024320576900953?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

https://api.elsevier.com/content/article/PII:0024320576900953?httpAccept=text/plain

7 May 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

7 May 2022

1 reference

14 September 2017

19

1 reference

14 September 2017

1507-1515

1 reference

14 September 2017

10

1 reference

14 September 2017

Vienna Clinical Weekly

5

81

10

Birkmayer

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.

7 May 2022

9

27

95

Kazamatsuri

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia

7 May 2022

10

14

189

Klawans

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

7 May 2022

11

38

1236

Ehringer

1960

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia

7 May 2022

12

97

457

Bird

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia.

7 May 2022

16

21

39

Messiha

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia

7 May 2022

17

46

323

Pind

1970

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

A pharmacologic analysis of Huntington's chorea

7 May 2022

19

4

148

Klawans

1970

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Pharmacologically Induced Behavioural Supersensitivity to Apomorphine

7 May 2022

20

245

262

Tarsy

1973

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

7 May 2022

21

13

927

Tarsy

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Cholinergic-anticholinergic antagonism in parkinsonism.

7 May 2022

25

17

124

Duvoisin

1967

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine.

7 May 2022

26

117

665

McGeer

1961

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Central cholinergic-anticholinergic antagonism in Huntington's chorea

7 May 2022

28

22

107

Klawans

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Effect of cholinergic and anticholinergic agents on tardive dyskinesia

7 May 2022

29

37

941

Klawans

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Cholinergic suppression of tardive dyskinesia

7 May 2022

30

37

101

Fann

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Cholinergic and dopaminergic mechanisms in Huntington's chorea

7 May 2022

31

10

405

Aquilonius

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Physostigmine in choreiform movement disorders

7 May 2022

32

24

28

Tarsy

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Letter: Deanol for tardive dyskinesia

7 May 2022

38

292

926

Crane

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Letter: Deanol for tardive dyskinesia

7 May 2022

39

292

926

Granacher

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Deanol in tardive dyskinesia: a preliminary report

7 May 2022

40

42

135

Fann

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

A technique for the study of acetylcholine turnover in mouse brain in vivo

7 May 2022

41

16

695

Schuberth

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

On the turnover of acetylchonine in nerve endings of mouse brain in vivo

7 May 2022

42

17

461

Schuberth

1970

0 references

The Luminosity–Spectral Index Relationship for Radio Galaxies

43

238

88

Haubrich

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Acetylcholine turnover estimation in brain by gas chromatography-mass spectrometry.

7 May 2022

45

14

55

Jenden

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Increase in rat brain acetylcholine induced by choline or deanol

7 May 2022

49

17

975

Haubrich

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Brain acetylcholine: Increase after systematic choline administration

7 May 2022

50

16

1095

Cohen

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Brain Acetylcholine: Control by Dietary Choline

7 May 2022

51

191

561

Cohen

1976

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

Simultaneous measurement of endogenous and deuterium-labeled tracer variants of choline and acetylcholine in subpicomole quantities by gas chromatography/mass spectrometry

7 May 2022

53

55

438

Jenden

1973

1 reference

https://api.crossref.org/works/10.1016/0024-3205(76)90095-3

7 May 2022

Identifiers

1 reference

14 September 2017

1 reference